Index | NOA group (n = 5) | Control group (n = 5) | P-value |
---|---|---|---|
Age (years) | 31.20 ± 4.87 | 28.40 ± 8.79 | 0.292 |
FSH (IU/L) | 21.53 ± 9.67* | 6.46 ± 1.25 | 0.009 |
LH (IU/L) | 12.00 ± 5.79* | 3.59 ± 0.52 | 0.009 |
T (ng/ml) | 2.99 ± 0.40 | 4.36 ± 1.26 | 0.075 |
PRL (ng/ml) | 10.97 ± 3.05 | 8.89 ± 1.50 | 0.116 |
E2 (pg/ml) | 21.13 ± 6.4 | 30.16 ± 7.32 | 0.076 |
P (ng/ml) | 0.25 ± 0.11 | 0.42 ± 0.20 | 0.059 |
Left testis volume (ml) | 6.40 ± 1.67* | 12.80 ± 2.95 | 0.014 |
Right testis volume (ml) | 6.40 ± 1.67* | 12.80 ± 2.95 | 0.014 |
Number of patients with abnormal secondary sexual characteristics no./total no. (%) | 0/5 (0) | 0/5 (0) | 1.000 |
Number of patients with varicocele no./total no. (%) | 0/5 (0) | 0/5 (0) | 1.000 |
Number of patients with genital abnormalities no./total no. (%) | 0/5 (0) | 0/5 (0) | 1.000 |
Number of patients with abnormal karyotype no./total no. (%) | 0/5 (0) | 0/5 (0) | 1.000 |
Number of patients with Y chromosome microdeletions no./total no. (%) | 0/5 (0) | 0/5 (0) | 1.000 |